阿帕提尼布通过刺激TFEB驱动的溶酶体生物发生来降解病毒蛋白来抑制HTNV
Qikang Ying1, Xiaoxiao Zhang1, Tianle Gu2
1Department of Microbiology, School of Basic Medicine, Air Force Military Medical University, Xi'an, China.
Antiviral research
|February 28, 2025
概括
阿帕提尼布是一种激酶抑制剂,通过增强病毒蛋白质的溶解体降解来有效抑制汉坦病毒 (HTNV) 感染. 这一发现为患有综合征 (HFRS) 的出血性发烧提供了一个有前途的新疗法策略.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 汉丹骨髓炎病毒 (HTNV) 导致综合征 (HFRS) 的出血发烧,这对人类健康构成重大威胁.
- 目前对HFRS的治疗选择有限,缺乏持久的疫苗或特定的抗病毒药物,凸显了对新型治疗策略的需求.
研究的目的:
- 为了确定针对宿主的抑制剂,以有效治疗HTNV感染的抗病毒药物.
- 调查针对病毒复制必不可少的宿主因子的已识别化合物的抗病毒机制.
主要方法:
- 选了2570种药物的库,以确定抑制HTNV感染的化合物.
- 在体外和体内都评估了已识别的化合物的疗效.
- 进行了机制研究,以阐明化合物准的抗病毒途径.
主要成果:
- 作为一种激酶抑制剂的阿帕蒂尼布被确定为HTNV感染的强大抑制剂.
- 阿帕提尼布通过抑制PI3K-Akt信号通路和减少mTOR酸化来向转录因子EB (TFEB).
- 这导致增强的TFEB核转移,增加了 lysosomal 功能,并随后降解病毒核囊蛋白.
结论:
- 阿帕提尼布通过调节宿主细胞机械来证明对HTNV具有显著的抗病毒活性.
- 该药物刺激了溶酶体介导的抗病毒机制,为HFRS提供了一种新的治疗方法.
- 这项研究提供了对病毒与宿主相互作用以及对抗病毒感染的潜在策略的宝贵见解.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
447
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
447
Immune Response Against Viral Pathogens
725
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
725
ATP Driven Pumps III: V-type Pumps
3.5K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.5K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
123
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
123


